Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Prestige Consumer Healthcare (PBH) Non Operating Income (2016 - 2025)

Historic Non Operating Income for Prestige Consumer Healthcare (PBH) over the last 17 years, with Q4 2025 value amounting to -$20.7 million.

  • Prestige Consumer Healthcare's Non Operating Income fell 7511.01% to -$20.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$55.7 million, marking a year-over-year decrease of 512.58%. This contributed to the annual value of -$52.6 million for FY2025, which is 2080.9% up from last year.
  • According to the latest figures from Q4 2025, Prestige Consumer Healthcare's Non Operating Income is -$20.7 million, which was down 7511.01% from -$10.5 million recorded in Q3 2025.
  • Over the past 5 years, Prestige Consumer Healthcare's Non Operating Income peaked at -$10.0 million during Q2 2025, and registered a low of -$30.6 million during Q1 2021.
  • For the 5-year period, Prestige Consumer Healthcare's Non Operating Income averaged around -$16.5 million, with its median value being -$16.5 million (2022).
  • In the last 5 years, Prestige Consumer Healthcare's Non Operating Income crashed by 318645.16% in 2021 and then surged by 4614.58% in 2022.
  • Over the past 5 years, Prestige Consumer Healthcare's Non Operating Income (Quarter) stood at -$17.1 million in 2021, then dropped by 11.5% to -$19.1 million in 2022, then increased by 9.49% to -$17.3 million in 2023, then skyrocketed by 31.58% to -$11.8 million in 2024, then tumbled by 75.11% to -$20.7 million in 2025.
  • Its last three reported values are -$20.7 million in Q4 2025, -$10.5 million for Q3 2025, and -$10.0 million during Q2 2025.